Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Transplant Proc. 2010 Sep;42(7):2650–2652. doi: 10.1016/j.transproceed.2010.04.065

Table 2. Outcomes after SPKTx in Study Cohort.

Outcomes T1DM T2DM
Clinical acute kidney rejection, % + ve 10 30
Clinical acute pancreas rejection, % + ve 15 10
% with mean HbA1C > 6.0 at 1 months 38 20
% with mean HbA1C > 6.0 at 12 months * 8 0
CrCl 1 month (MDRD equation) Mean +/-SD 69 +/- 25 60 +/- 12
CrCl 12 month (MDRD equation) Mean +/- SD * 68 +/- 24 69 +/- 22
*

patients with >/=1 year follow-up